NZCR is New Zealand’s leading early phase clinical research provider.
Home / About Us / About NZCR
NZCR, formed in 2020 by the merger of Auckland Clinical Studies (ACS) and Christchurch Clinical Studies Trust (CCST) is New Zealand’s leading early phase stage clinical research provider.
The merger of the ACS and CCST research teams brings together over 35 years combined research excellence, a track record of completing over 500 trials involving over 15,000 participants and provides expanded scale and capability.
With physician led, world class research units located in Auckland and Christchurch, NZCR conducts complex early phase clinical research in healthy participant and patient populations.
We partner with global pharmaceutical and biotechnology companies to deliver excellence in clinical research and investigate potential new medicines.
NZCR values the key role of our study participants in clinical research. We provide detailed study information, expert clinical care, and support services to ensure the safety and comfort of all our participants. Study participants are compensated for their time, inconvenience and travel.
New Zealand Clinical Research (NZCR) provides state of the art research facilities and the expertise to conduct complex early phase clinical research in healthy participant and patient populations.